Triple
T20061699
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ABVD regimen |
E499490
|
entity |
| Predicate | acronymFor |
P590
|
FINISHED |
| Object | Bleomycin |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Bleomycin | Statement: [ABVD regimen, acronymFor, Bleomycin]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Bleomycin Context triple: [ABVD regimen, acronymFor, Bleomycin]
-
A.
bleomycin
chosen
Bleomycin is an antitumor antibiotic chemotherapy drug commonly used to treat cancers such as Hodgkin lymphoma and testicular cancer.
-
B.
Dacarbazine
Dacarbazine is a chemotherapy drug primarily used to treat Hodgkin lymphoma and certain types of sarcoma.
-
C.
adriamycin
Adriamycin is the brand name for doxorubicin, an anthracycline chemotherapy drug widely used to treat various cancers including lymphomas, leukemias, and solid tumors.
-
D.
mitoxantrone
Mitoxantrone is an anthracenedione chemotherapeutic agent used primarily to treat certain cancers and multiple sclerosis by intercalating DNA and inhibiting topoisomerase II.
-
E.
cyclophosphamide
Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69da6276bcf48190aabbf279192a5fb4 |
completed | April 11, 2026, 3:02 p.m. |
| NER | Named-entity recognition | batch_69e6637601dc8190a07fc20844093cb7 |
completed | April 20, 2026, 5:33 p.m. |
Created at: April 11, 2026, 3:38 p.m.